Takeda Loses Bid to Nix $155 Million Bayer Win in Drug Case

Login to Listen
(Bloomberg) -- Takeda Pharmaceutical Co.‘s Baxalta unit lost its bid to overturn a $155 million jury verdict won by Bayer AG for royalties from sales of a hemophilia drug.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.